Erythropoietin in kidney disease and type 2 diabetes.
Francesco
F
Locatelli
Lucia
L
Del Vecchio
Donatella
D
Casartelli
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002097:C-Reactive Protein / Q000032:analysis; D000068256:Darbepoetin alfa; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D012306:Risk
D006397:Hematinics; D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D002097:C-Reactive Protein